Retrospective Evaluation of the Percentage of Subjects Who Have Reached Their LDL-C Objectives After Treatment With INEGY (Study P05103)(COMPLETED)

• Status: Completed
• Trial end date: 2008-08-01
• Target enrollment: 0
• Participant gender: All

Summary

The main objective of this study is to determine the percentage of patients who met the low-density lipoprotein cholesterol (LDL-C) objective with INEGY, that were not under statin monotherapy treatment.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Merck Sharp & Dohme Corp.
• Treatments: Ezetimibe, Simvastatin Drug Combination

Criteria

Inclusion Criteria:

• man or woman aged over 18;

• patient suffering from primary hypercholesterolemia;

• patient justifying treatment with INEGY® (2nd intention);

• patient currently treated with INEGY® for at least 4 weeks;

• patient with a lipid profile before treatment with INEGY®, documenting a level of LDL-C exceeding the therapeutic objective under treatment with a statin as monotherapy;

• patient with an evaluation of lipid disorder (EAL) treated with INEGY®, performed within 1 to 3 months of starting treatment.

Exclusion Criteria:

• patient not previously treated with a statin;

• patient previously treated with a combination of hypolipemics;

• patient treated with INEGY® as first intention;

• patient treated with INEGY® for less than 4 weeks;

• patient already included in this study.